Results 151 to 160 of about 44,633 (211)

Clinical outcomes with vutrisiran in transthyretin amyloidosis: a systematic review and meta-analysis of randomized trials. [PDF]

Glob Cardiol Sci Pract
Ahmed F, Haider F, Zulfiqar A, Nihal T, Khalid M, Dar A, Rauf S, Saleem NUA, Farooq H, Tahir HB, Ali R, Shah HH, Patel S, Hossain M, Alenezi F.   +14 more
europepmc   +1 more source

Contemporary real-world treatment of cardiac transthyretin amyloidosis with tafamidis: a long-term multicentre study. [PDF]

ESC Heart Fail
Nies RJ, Ney S, Kindermann I, Bewarder Y, Zimmer A, Knebel F, Hahn K, Spethmann S, Luedike P, Michel L, Rassaf T, Papathanasiou M, Störk S, Cejka V, Polzin A, Voß F, Unsöld B, Meindl C, Paulus M, Yilmaz A, Chamling B, Morbach C, Pfister R.   +22 more
europepmc   +1 more source

Autonomic dysfunction in patients with wild-type transthyretin amyloidosis. [PDF]

J Neurol
Kleinveld VEA, Wanschitz J, Hotter A, Horlings CGC, Leys F, Ungericht M, Pölzl G, Granata R, Fanciulli A, Löscher WN.   +9 more
europepmc   +1 more source

Vutrisiran in East Asian Patients With Transthyretin Amyloidosis With Cardiomyopathy: Post-Hoc Analysis of HELIOS-B. [PDF]

JACC Asia
Endo J, Minamino T, Oh J, Tahara N, Tsujita K, Izumi C, Okumura T, Onoue K, Kitaoka H, Chen C, Chan-Daniels A, Kim D.   +11 more
europepmc   +1 more source

Disease Prognosis and Progression in Transthyretin Amyloidosis: JACC: CardioOncology State-of-the-Art Review. [PDF]

JACC CardioOncol
Vaishnav J, Bampatsias D, Boursiquot BC, Brailovsky Y, Hsu K, Zigterman J, Chakraborty R, Wechalekar A, Pavia PG, Witteles R, Hanna M, Karam C, Maurer MS, Griffin JM.   +13 more
europepmc   +1 more source

The patient's voice: real-world experiences of a transthyretin amyloidosis focus group. [PDF]

BMC Health Serv Res
López MA, Ripoll-Vera T, Sevilla T, Salamanca-Bautista P, Mediavilla I, Soto JF, CARABELA-ATTR Scientific Committee.   +6 more
europepmc   +1 more source

Mortality in octogenarian patients with transthyretin amyloidosis treated with tafamidis: a systematic review and meta-analysis. [PDF]

Orphanet J Rare Dis
Santo C, Correia VM, Defante MLR, Barbosa BFS, Dabarian A, Bueno BVK, Junior VM, Fernandes F.   +7 more
europepmc   +1 more source

Evaluation of serum neurofilament light chain, GFAP, and peripherin as biomarkers in hereditary transthyretin amyloidosis. [PDF]

Sci Rep
Anan I, Johannson G, Pilebro B, Wixner J, Heldestad V, Arvidsson S, Olsson M.   +6 more
europepmc   +1 more source